Howe & Rusling Inc Emergent Bio Solutions Inc. Transaction History

Howe & Rusling Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$36.48 - $52.22 $2,553 - $3,655	-70 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$50.07 - $66.05 $250 - $330	5 Added 7.69%	70 $4,000
Q2 2021 Aug 13, 2021	BUY	$56.61 - $80.46 $452 - $643	8 Added 14.04%	65 $4,000
Q1 2021 May 13, 2021	BUY	$86.23 - $125.19 $2,241 - $3,254	26 Added 83.87%	57 $5,000
Q3 2020 Nov 06, 2020	SELL	$81.91 - $134.94 $1,556 - $2,563	-19 Reduced 38.0%	31 $3,000
Q2 2020 Jul 15, 2020	SELL	$54.33 - $89.52 $12,767 - $21,037	-235 Reduced 82.46%	50 $4,000
Q1 2019 Apr 29, 2019	SELL	$48.23 - $66.16 $6,752 - $9,262	-140 Reduced 32.94%	285 $14,000
Q4 2018 Feb 04, 2019	SELL	$55.63 - $73.24 $37,272 - $49,070	-670 Reduced 61.19%	425 $25,000
Q3 2018 Nov 07, 2018	SELL	$52.05 - $66.51 $198,310 - $253,403	-3,810 Reduced 77.68%	1,095 $72,000
Q3 2017 Oct 18, 2017	BUY	$34.14 - $40.45 $167,456 - $198,407	4,905	4,905 $198,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $420M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.